欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/V/0125/001
药品名称Triquest
活性成分
    • sulfadiazine 333.0 mg/ml
    • trimethoprim 67.0 mg/ml
剂型Oral suspension
上市许可持有人Alfasan Nederland B.V. Netherlands
参考成员国 - 产品名称Sweden (SE)
Triquest Vet
互认成员国 - 产品名称
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Germany (DE)
    • Bulgaria (BG)
    • Belgium (BE)
    • Cyprus (CY)
    • Netherlands (NL)
    • Czechia (CZ)
    • Luxembourg (LU)
    • Romania (RO)
    • Iceland (IS)
    • Slovakia (SK)
    • Ireland (IE)
    • Slovenia (SI)
    • Austria (AT)
    • Croatia (HR)
    • France (FR)
      TRIQUEST 333 MG/ML + 67 MG/ML SUSPENSION BUVABLE POUR CHEVAUX
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
许可日期2024/05/08
最近更新日期2024/05/09
药物ATC编码
    • QJ01EW10 sulfadiazine and trimethoprim
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase